药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Yohimbine
Danaparoid
The risk or severity of hyperkalemia can be increased when Danaparoid is combined with Fimasartan.
Yohimbine
Bufuralol
The risk or severity of hyperkalemia can be increased when Bufuralol is combined with Fimasartan.
Yohimbine
Nilvadipine
The risk or severity of hyperkalemia can be increased when Nilvadipine is combined with Fimasartan.
Yohimbine
Dotarizine
The risk or severity of hyperkalemia can be increased when Dotarizine is combined with Fimasartan.
Yohimbine
Sulodexide
The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Fimasartan.
Yohimbine
Nylidrin
The risk or severity of hyperkalemia can be increased when Nylidrin is combined with Fimasartan.
Yohimbine
Seletracetam
The risk or severity of hyperkalemia can be increased when Seletracetam is combined with Fimasartan.
Yohimbine
Methsuximide
The risk or severity of hyperkalemia can be increased when Methsuximide is combined with Fimasartan.
Yohimbine
Clevidipine
The risk or severity of hyperkalemia can be increased when Clevidipine is combined with Fimasartan.
Yohimbine
Celiprolol
The risk or severity of hyperkalemia can be increased when Celiprolol is combined with Fimasartan.
Yohimbine
Fluspirilene
The risk or severity of hyperkalemia can be increased when Fluspirilene is combined with Fimasartan.
Yohimbine
Flunarizine
The risk or severity of hyperkalemia can be increased when Flunarizine is combined with Fimasartan.
Yohimbine
Cyclandelate
The risk or severity of hyperkalemia can be increased when Cyclandelate is combined with Fimasartan.
Yohimbine
Prenylamine
The risk or severity of hyperkalemia can be increased when Prenylamine is combined with Fimasartan.
Yohimbine
Penicillin G Acyl-Serine
The risk or severity of hyperkalemia can be increased when Penicillin G Acyl-Serine is combined with Fimasartan.
Yohimbine
Canrenone
The risk or severity of hyperkalemia can be increased when Fimasartan is combined with Canrenone.
Yohimbine
Canrenoic acid
The risk or severity of hyperkalemia can be increased when Canrenoic acid is combined with Fimasartan.
Yohimbine
Cilazaprilat
The risk or severity of adverse effects can be increased when Fimasartan is combined with Cilazaprilat.
Yohimbine
Moxonidine
The risk or severity of adverse effects can be increased when Fimasartan is combined with Moxonidine.
Yohimbine
Indoramin
The risk or severity of adverse effects can be increased when Fimasartan is combined with Indoramin.